Can Microsatellite Status of Colorectal Cancer Be Reliably Assessed after Neoadjuvant Therapy?

导出 OA

翻译打印收藏纠错

作者： Jennifer B,Goldstein ^[1] ; William,Wu ^[2] ; Ester,Borras ^[2] ; Gita,Masand ^[2] ; Amanda,Cuddy ^[3] ; Maureen E,Mork ^[4] ; Sarah A,Bannon ^[4] ; Patrick M,Lynch ^[4] ; Miguel,Rodriguez-Bigas ^[5] ; Melissa W,Taggart ^[3] ; Ji,Wu ^[4] ; Paul,Scheet ^[6] ; Scott,Kopetz ^[1] ; Y Nancy,You ^[7] ; Eduardo,Vilar ^[1]

作者单位： Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[1] Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[2] Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[3] Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[4] Department of Gastroenterology, Hepatology & Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[5] Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[6] Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[7] Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. EVilar@mdanderson.org. ^[8]